US SEC Filing Intelligence

DHS Homeland Security Contracts — October 10, 2026

This DHS stream covers two contracts totaling $53,955,338 in obligations, both civilian (0 of 2 defense-related), with no direct defense exposure. The dominant theme is DHS professional and physical security services: LMI Consulting, LLC holds a $36,634,684 time-and-materials program management delivery order for the Office of National Laboratories, and First Coast Security Solutions, Inc. holds a $17,320,654 firm fixed-price Protective Security Officer award under FPS for Rockville, MD. Both awards were made under full and open competition with no set-aside, and both carry neutral signals (average strength 3.0/10, materiality 2-3/10). The highest-conviction observation is multi-year revenue visibility through 2027 and 2028, but neither contract is confirmed as investable through a public parent. The key watch item is outlay pace and option exercise: LMI has roughly $11.7 million of obligated funds remaining before its March 31, 2027 end date, and First Coast's $17.3 million obligation sits at about 47% of its $36,984,200 base-plus-options ceiling.

2 total filings

VA Healthcare & Services Contracts — October 10, 2026

This digest covers a single VA Healthcare & Services contract totaling $18,112,864 in obligation, with zero defense-related awards, so the defense/civilian split is 0% defense and 100% civilian. The dominant theme is VA demand for emergency physician staffing, evidenced solely by the White Stone Spectrum Healthcare Resources LLC award from VA Network Contracting Office 6 (36C246). The highest-conviction signal is that the award is a firm fixed-price, SDVOSB set-aside contract running through 2027-03-31, which points to durable but narrowly-scoped agency demand. The key watch item is the reported $0 outlayed against the full $18,112,864 obligation, which should be tracked to confirm performance and billing. Because the recipient is a private LLC with no identified public-market ticker, direct equity implications are limited, and the overall signal strength for this stream is low at 3.0/10.

New Federal Contractors — October 10, 2026

The 15 new federal contract awards in this period total $366,409,794 in obligations, with zero defense-related awards; all are civilian, spanning USDA Forest Service (aerial firefighting), GSA, DHS, NASA, EPA, VA, and DOL. The dominant theme is USDA Forest Service wildland fire aviation, with four airtanker and fire-suppression delivery orders (Coulson Aviation, AERO-FLITE, AERO AIR, PRECISION) totaling roughly $113.4M. The highest-conviction signal is the cluster of firm-fixed-price USDA aviation orders that are already 73-87% outlayed, indicating active performance rather than speculative backlog. The key watch item is that most of the largest awards depend on unexercised options and none of the recipients are identified as publicly traded, so direct equity read-through is limited; option exercises and the 2026-12-31 current end dates on the USDA orders are the critical near-term triggers.

Significant Contract Modifications ($10M+) — October 10, 2026

The 15 significant contract modifications in this October 10, 2026 snapshot total $366,409,794 in obligations, with zero defense-related awards; all 15 are civilian agency actions spanning USDA Forest Service (aerial firefighting), NASA (space R&D and launch support), GSA, DHS, DOL, EPA, and VA. The dominant theme is USDA Forest Service fire-suppression aviation, which accounts for the largest cluster of material awards (AIRTANKER and Type II exclusive-use delivery orders to Coulson Aviation, AERO-FLITE, AERO AIR, and PRECISION, totaling roughly $113.4M). The highest-conviction signal is the breadth of multi-year, firm-fixed-price aviation work extending to 2026-2028, though none of the recipients identified in the data is tied to a publicly traded parent, so direct equity read-through is minimal. The key watch item is the large unobligated gap between obligated and base-plus-options values (e.g., roughly $21.3M for AERO-FLITE and $18.0M for AERO AIR), which depends on option exercise and wildfire-season demand; the data does not establish any budget trend.

Contract Deobligations Alert — October 10, 2026

The 15 contracts in this October 10, 2026 deobligations stream total $366,409,794 in obligations, with zero defense-related awards and all 15 classified as civilian (USDA Forest Service, DOL, DHS, GSA, NASA, VA, EPA). The dominant theme is federal aerial wildland fire suppression at USDA, where Coulson Aviation (USA), AERO-FLITE, AERO AIR, and PRECISION together account for roughly $113.4M of obligations across four airtanker and Type II exclusive-use delivery orders. The highest-materiality signal is Coulson Aviation's $37,445,652 obligation (materiality 3/10, the top of the set), but every recipient in the set is either privately held, nonprofit, or lacks a identified public parent, so none offers a clear listed-equity exposure. The key watch item is option exercise and outlay pace across the Forest Service aviation awards, since large portions of stated ceiling values ($21.3M for AERO-FLITE, $18.0M for AERO AIR) remain contingent on unexercised options.

Contract Option Exercises — October 10, 2026

The 15 contract option exercises in this period total $366,409,794 in obligations, with zero defense-related awards and all 15 classified as civilian (USDA Forest Service, DOL, DHS, GSA, NASA, EPA, VA). The dominant theme is USDA Forest Service aerial firefighting aviation, which accounts for five awards (Coulson Aviation $37,445,652; Aero-Flite $29,432,912; Aero Air $28,245,578; Precision LLC $18,280,005) totaling roughly $113M, though none of these recipients appear to be publicly traded in the data. The highest-conviction read is that federal wildland fire aviation spending remains sustained through 2026-2028 potential end dates, but the data contains no budget trend series to confirm direction. Most recipients are private, nonprofit, or subsidiary entities with no identified public ticker, so direct equity implications are limited; the principal watch item is option exercise status, since roughly $100M+ of stated base-plus-options value remains unobligated across the aviation and other awards.

Federal Professional Services Contracts — October 10, 2026

This digest covers a single federal professional services contract totaling $36,634,684 in obligations, awarded to LMI Consulting, LLC by the Department of Homeland Security's Office of Procurement Operations for program management support to the Office of National Laboratories. The record is entirely civilian (0 of 1 defense-related), so there is no defense/civilian split to analyze, and the dominant theme is DHS program management spending under a time-and-materials delivery order. The highest-conviction signal is the contract's mechanical drawdown profile: roughly $24.9 million (about 68%) has been outlayed against the obligation, with performance running through March 31, 2027. The primary watch item is whether the remaining roughly $11.7 million in obligated funds is fully expended before that end date and whether a follow-on recompete is issued. Given the contract's modest size against a multi-trillion-dollar federal budget and the private, non-public status of the recipient, this record carries limited direct investment relevance and no actionable public-equity signal.

NASA & Space Contracts Intelligence — October 10, 2026

The three NASA-related awards in this period total $58,821,391 in obligations (Caltech/JPL $23,169,745; University System of New Hampshire $18,509,068; Airborne Systems North America $17,142,577), with zero defense-related records, so the entire digest is civilian-agency space R&D. The dominant theme is NASA science and planetary-exploration hardware and research funding, spanning the Human Landing System support at JPL, the HELIOSWARM program at NASA Ames, and the Dragonfly Titan lander parachute subsystem at NASA Langley. The highest-conviction read is the Airborne Systems North America award, a cost-plus-fixed-fee contract with 81% of its obligation already outlayed, though its materiality to parent TransDigm Group cannot be determined from the data. Signal strength averages only 2.7/10 and all three signals are neutral, so no bullish or bearish call is warranted on the contract data alone. The key watch item is the pace of outlays and option exercises through the 2026-2027 end dates, particularly the USNH contract ending 2026-10-31 and the Airborne contract ending 2027-04-30.

3 total filings

High-Value Federal Grants ($5M+) — October 10, 2026

The 15 contracts in this period total $366,409,794 in obligations, with zero defense-related awards; the entire slate is civilian, spanning USDA Forest Service, DOL, DHS, GSA, NASA, EPA, and VA. The dominant theme is wildland fire suppression aviation, where four USDA Forest Service airtanker/aviation delivery orders (AERO-FLITE $29,432,912, AERO AIR $28,245,578, Precision LLC $18,280,005, plus Coulson Aviation $37,445,652) account for roughly $113.4M of the total. The highest-conviction signal is the steady outlay progression on these fire aviation awards, which indicates active 2024-2026 operations, though the recipients are private and largely not investable. The key watch item is option exercise and extension decisions on the Forest Service orders ahead of the 2026-12-31 current end dates, since roughly $18-21M of base-plus-options value on several awards remains unobligated. Overall, the period carries no direct public-equity catalyst; the 15 signals are neutral in the data, with recipients mostly privately held or nonprofit.

General Federal Contracts — October 10, 2026

Across 15 federal contracts totaling $366,409,794 in obligations dated October 10, 2026, none are defense-related; all are civilian, spanning USDA Forest Service, NASA, DHS, GSA, VA, EPA, and DOL. The dominant theme is USDA Forest Service aerial firefighting procurement, which accounts for several of the largest awards (Coulson Aviation $37,445,652, AERO-FLITE $29,432,912, AERO AIR $28,245,578, PRECISION LLC $18,280,005). Every contract is rated neutral with an average signal strength of 2.9/10, and the provided data identifies no publicly traded recipient with a clearly disclosed parent, so direct equity read-throughs are weak. The highest-conviction observation is the sustained, multi-year demand for wildfire aviation capacity, though the data offers no budget trend to confirm its direction. The key watch item is option exercise and outlay pace on the aviation delivery orders, whose current end dates of 2026-12-31 fall close to the potential end dates of 2028-12-31 and rely on options the data does not confirm.

All NASA Contracts — October 10, 2026

Four NASA contracts totaling $75,515,990 in obligations were recorded for the period October 10, 2026, with zero defense-related awards, so the entire digest is civilian-space in character. The dominant theme is NASA science and exploration R&D delivered largely through university and nonprofit recipients (Caltech/JPL, University System of New Hampshire, University of Alaska Fairbanks) plus one publicly linked hardware supplier, Airborne Systems North America (a TransDigm Group subsidiary). The highest-conviction read is limited: the Airborne Systems award ($17,142,577, cost-plus-fixed-fee, full and open competition, roughly 81% outlayed) is the only contract with a traceable public-equity parent, but the data does not disclose TransDigm's consolidated materiality, so no bullish or bearish call is warranted. Signal strength averages 2.5/10 across all four records, and every record is rated neutral; the principal watch item is option exercise and outlay pace on the Airborne Systems and Caltech/JPL contracts, which together account for roughly $40M of the aggregate value.

4 total filings

Biotech Small-Cap Approvals — October 09, 2026

This digest covers a single FDA approval recorded for the period October 09, 2026 to October 09, 2026, within the Biotech Small-Cap Approvals stream. The approval mix is 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other action, so no first-in-class or new molecular entity signal is present. The only event is the SHANDONG approval of sugammadex sodium, classified in the source data as a FALLBACK approval type and labeled a biosimilar in its summary, though the analysis rests on limited detail. With one approval and a neutral signal (strength 5/10, materiality 5/10), no therapeutic area cluster or sector theme can be established from this period. The key watch item is whether the classification and commercial terms for sugammadex are confirmed, since peak sales, exclusivity, pricing power, and market position are all NOT_DISCLOSED.

Orphan Drug Approvals — October 09, 2026

This digest covers a single FDA action in the Orphan Drug Approvals stream for the period October 9, 2026, with the approval mix at 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other action. The sole approval is a label expansion-category action recorded as FALLBACK for TUCATINIB (TUKYSA) from SEAGEN, dated October 7, 2026, carrying a bullish signal (strength 5/10, materiality 5/10). No therapeutic area clustering is observable from a single data point, so no sector-level momentum signal can be drawn. The highest-conviction signal is the bullish read on SEAGEN's continued commercial support of TUKYSA, but the source data does not disclose the indication, peak sales, exclusivity, pricing power, or market position, limiting the investment conclusion. The key watch item is that the approval type is classified as FALLBACK rather than a standard label expansion, which warrants verification of the regulatory pathway and scope before sizing any position.

New Drug Approvals (Original) — October 09, 2026

This digest covers a single FDA approval recorded between October 9, 2026 and October 9, 2026, with a mix of 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other approval. The lone event is SUGAMMADEX SODIUM from SHANDONG, categorized under a FALLBACK approval pathway and flagged as a biosimilar-type approval in the source analysis, with a neutral signal (strength 5/10, materiality 5/10). No therapeutic area clustering is observable from one approval, so no sector momentum signal can be drawn. Commercial parameters including peak sales, exclusivity, pricing power, and market position are NOT_DISCLOSED, limiting the depth of investment conclusions. The primary watch item is the lack of disclosed market-position and exclusivity data, which means the commercial read-through for originator Merck or competing sugammadex generics cannot be quantified from the provided data.

DHS Homeland Security Contracts — October 09, 2026

The eight DHS awards in this period total $178,083,908 in obligations, all civilian and none defense-related, with CBP and USCIS as the dominant buyers and IT, cybersecurity, facilities, and biometric R&D as the core scopes. The highest-conviction signal is the USCIS time-and-materials delivery order to SALIENT CRGT (parent GOVCIO, LLC), with a $23,895,601 current obligation inside a $163,395,565 ceiling and a potential end date of 2030-11-06, though only about 15% of the ceiling is currently obligated. Awards are split between open-competition wins (SAIC, Anduril, Accenture Federal, Definitive Logic, SALIENT CRGT) and set-aside or small-business awards (Spatial Front's 8(a) order, Brown Point's woman-owned small business order). Most recipients are private or have no public-market linkage evident in the data, so equity impact is largely indirect; the watch item is option exercise and outlay pace across the largest orders, particularly SALIENT CRGT's 2026-11-06 current end date. Signals are uniformly neutral in the source analyses, and this digest does not inflate the bullish count.

8 total filings

VA Healthcare & Services Contracts — October 09, 2026

The 16 VA Healthcare & Services contracts total $1,139,115,013 in obligations, with zero defense-related awards; the entire stream is civilian, dominated by Department of Veterans Affairs construction, facilities, and IT/services work. The highest-materiality award is TriWest Healthcare Alliance Corp's $900,485,186 delivery order, which accounts for about 79% of the aggregate but shows $0 outlayed and a one-month performance period, so its recurrence is unverified. Beyond that outlier, the remaining 15 awards range from roughly $10.9M to $23.9M, are overwhelmingly set-aside construction contracts to SDVOSBs, and show $0 outlayed in most cases, meaning realized revenue is largely unestablished. The highest-conviction signal is the scale and concentration of the TriWest award as a single-agency demand event, while the principal watch item is whether outlays materialize against these obligations, since the stream's average signal strength is only 3.1/10 and no contract in the set can be tied to a publicly traded parent from the data provided.

16 total filings

HHS & Healthcare Contracts Intelligence — October 09, 2026

Two HHS/ASPR (BARDA) healthcare R&D contracts totaling $110,661,632 in obligations were recorded for the period, with zero defense-related awards, so the entire digest sits in the civilian HHS/healthcare stream. The dominant theme is BARDA funding for medical countermeasure and diagnostic readiness: Abbott Laboratories received $65,469,510 for clinical validation supporting an expanded FDA indication for its TBI diagnostic, and Basilea Pharmaceutica International received $45,192,122 in a cost-sharing contract for antibiotics against drug-resistant gram-negative bacteria. The highest-conviction signal is the Abbott award, given its scale, firm-fixed-price structure, and clear path to an FDA marketing application, though this is government R&D funding rather than product revenue and only about 21% of its obligation has been outlayed. Both signals are rated neutral (average strength 3.5/10), and the key watch item is the outlay pace and option exercise on Basilea's contract, where only about 45% of the current obligation has been spent against a $191,938,367 ceiling. Revenue materiality to either parent company cannot be established from the provided data.

2 total filings